Abstract
Introduction

Microvascular complications are major contributors to morbidity, mortality and costs of both non-insulin-dependent (NIDDM) and insulin-dependent diabetes mellitus (IDDM) [1]. Damage of the small vessels in the kidney can lead to end-stage renal disease, structural alterations of the smaller vessels that supply nutrients and oxygen to peripheral nerves contribute to neuropathy and damage of the microvasculature of the eye is the leading cause of loss of vision in working-age adults. The clinical manifestations of microvascular disease are so characteristic of the disease that diabetes itself is defined primarily by the level of hyperglycaemia which causes microvascular complications.
Alterations in the microcirculation involve small resistance arteries, arterioles, capillaries and post capillary venules. Mechanisms possibly involved in the development of microvascular alterations are summarized in Table 1 . A relevant role in the impairment of vascular distensibility may be played by advanced glycosylation end-products, which may be involved in the formation of collagen cross-links [2] . Changes in the mechanics of small vessels may also induce changes in the structure. Although there is a huge amount of data about microangiopathy (capillary and arterioles), very few data about morphology of small resistance arteries (diameter ranging from 100 to 350 m) in diabetes mellitus are presently available. In one study [3] , no difference in subcutaneous small artery structure was observed between control patients and patients with IDDM. On the contrary, it has been demonstrated that, in both hypertensive and normotensive patients with NIDDM, marked alterations in small artery structure are present [4] , and that these alterations are more pronounced in hypertensive patients with NIDDM than in patients with essential hypertension or in normotensive diabetics (Fig. 1) [4] . In addition, in diabetic patients a clear increase in the media cross-sectional area of the vessels was observed, thus suggesting the presence of hypertrophic remodelling (vascular smooth muscle cells hypertrophy or hyperplasia) [4, 5] (Fig. 2) . This was not the case of patients with essential hypertension, in which a eutrophic remodelling (re-arrangement of the same amount of wall material around a narrowed lumen) is usually observed [4, 5] .
A weak, but significant correlation between circulating levels of insulin and media to lumen ratio of subcutaneous small arteries was observed in diabetic patients, thus suggesting a possible role of insulin or insulin-like growth factor-1 in the genesis of hypertrophic remodelling in these patients [4] . However, an alternative explanation for the presence of hypertrophic remodelling in these vessels has been proposed [5] [5] of the lack of such a myogenic response in diabetic patients may therefore be responsible for the development of hypertrophic remodelling of small arteries (Fig. 3) [5] . Diabetic patients with NIDDM also show particularly evident alterations of the vascular extracellular matrix, as suggested by the observation of increased collagen to elastin ratio in their small arteries [4] (Fig. 1 [6] and also in patients with NIDDM, at least in the skeletal muscle [7] .
On [9] . An impaired microvascular hyperaemic response (which may reflect an altered flow reserve) has been observed in children with diabetes mellitus [10] as well as in adult patients with NIDDM [11] . Thus [5] [16] . Also vascular rarefaction may have important consequences in terms of tissue perfusion. In fact, it has been demonstrated that in patients with NIDDM, the mechanisms through which insulin is able to increase total limb flow or achieve optimal microvascular perfusion is impaired [7] . [4, 5, 24] . However, the concomitant presence of the two cardiovascular risk factors does not seem to induce a further worsening of endothelial function [4, 24] [4, 24] . No effect has been observed when indomethacin was added to the organ bath; therefore, the production of cyclooxygenase-dependent substances seems to be of minor importance [4, 24] .
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Endothelial dysfunction
An impairment of the endothelial function, as evaluated by the vasodilator response to acetylcholine, has been detected in large and small arteries of patients with IDDM [17-21] as well as of those with NIDDM [4, 5, 22-24]. Endothelial cells are known to have important regulatory effects on the cardiovascular system through the release of vasodilator and vasoconstrictor factors. In addition, platelet aggregation as well as leucocyte extravasation through endothelium may be influenced by locally produced compounds. Therefore, endothelial dysfunction and damage may contribute to the inflammatory and thrombotic vascular lesions. We and others have previously demonstrated the presence of an impaired dilatation to acetylcholine and bradykinin in subcutaneous small resistance arteries of hypertensive and normotensive patients with NIDDM
It has been also proposed that insulin and insulin resistance may be involved in the genesis of endothelial, and in general, microvascular dysfunction in diabetes mellitus. Insulin is able to induce a vasodilating effect in the microcirculation (which is, at least in part, endothelium dependent) in normal patients [25, 26] . In addition, insulin may recruit skeletal muscle capillaries in vivo by a nitric oxide dependent action, and this increased capillary recruitment may contribute to the subsequent glucose uptake [27] . However, part of these effects is lost in diabetes mellitus [25] . Hyperinsulinaemia, as a result of insulin resistance may have detrimental effects on microvascular function also in the prediabetic state [28] . On the other hand microvascular structural alterations may contribute to an impaired delivery of insulin to skeletal muscles [29] . Therefore, a complex interplay of structural and functional alterations of the microcirculation may, at least in part, explain the detrimental consequences of diabetes mellitus in terms of organ perfusion [30] , and, ultimately, in terms of increased incidence of cardiovascular events.
Effect of treatment
There are relatively few data about the effect of treatment on structural and functional alterations in the microcirculation of patients with diabetes mellitus. In the United Kingdom Prospective Diabetes Study, a large randomized controlled trial that included almost 5000 patients, it has been demonstrated that a tight haemodynamic and metabolic control is associated with a lower incidence of microvascular disease [31] , and, in general, of clinical end-points related to microvascular disease [32] .
Even fewer data are presently available about the effects of antihypertensive drugs on small artery structure in hypertensive diabetic patients. Despite effective antihypertensive treatment, resistance arteries from hypertensive diabetic patients showed marked remodelling, greater than that of vessels from untreated, non-diabetic, hypertensive patients, in agreement with the high cardiovascular risk of patients suffering from both diabetes and hypertension [33] . Recently, a study has compared the effects of 1-year treatment with the angiotensin-converting enzyme (ACE) inhibitor (enalapril) or the angiotensin II receptor blocker (candesartan), on subcutaneous small artery structure in hypertensive patients with NIDDM [34] . The two drugs were equally effective in reducing media to lumen ratio of small arteries (Fig. 4) [34] . Angiotensin II receptor blockers seem to be effective in diabetic hypertensive patients also when given on top of an ACE inhibitor treatment [35] . In addition, angiotensin II receptor blockers seem to be also particularly effective in terms of improvement of endothelial function in small resistance arteries [36] (Fig. 5) [38] . However, metabolic improvements enable eutrophic remodelling to occur in response to an increase in blood pressure [38] .
Development in the topic in the next years
The relative invasiveness of the fat tissue biopsy, the limited availability of the technique (performed in few laboratories) and the [36] 
